GenVec

Infobox_Company
company_name = GenVec, Inc.
company_
company_type = Public (NASDAQ-GM: [http://quotes.nasdaq.com/asp/SummaryQuote.asp?symbol=GNVC&selected=GNVC] )
company_slogan =
foundation =
location = Gaithersburg, Maryland, United States flagicon|USA
key_people = Paul H. Fischer, President & CEO
num_employees =
industry = Pharmaceuticals
products = TNFerade^TM Phase III
revenue =
operating_income =
net_income = loss$4.4 million USD (2007)
homepage = http://genvec.com/

GenVec, Inc. is a biopharmaceutical company developing pharmaceuticals and vaccines based on novel biotechnology such as targeted delivery systems. The company has a number of drugs currently in various phases of clinical trials. Its lead product candidate is TNFerade(TM), being developed for the treatment of solid tumors. The company has been contracted by the United State's Department of Homeland Security to develop a vaccine for Foot-and-mouth disease. [cite news
last = Sinha
first = Vandana
coauthors =
title = GenVec reports narrowed losses
work = Washington Business Journal
pages =
language = English
publisher = Advance Publications
date = 2008-03-14
url =
accessdate = 2008-04-04 ]

References